Andere Sprachen Merck & Co., Inc.

Aktien

A0YD8Q

US58933Y1055

MRK

Pharmazeutika

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:31:15 03.12.2024			% 5 Tage	% 1. Jan.
102.22 ^USD	+1.60%		+0.78%	-6.06%

13:56	Merck sagt, Lungenkrebsbehandlung erhält FDA-Zulassung für bahnbrechende Therapie	MT
12:45	Sacituzumab Tirumotecan von Merck erhält von der FDA den Status eines Therapiedurchbruchs für fortgeschrittenen EGFR-mutierten NSCLC	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Merck : 'percée thérapeutique' pour un anticorps-conjugué	14:48
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation	13:56
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations	12:46
Merck's Sacituzumab Tirumotecan Granted FDA Breakthrough Therapy Designation for Advanced EGFR-Mutated NSCLC	12:45
Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List	29.11.
Dr. Reddy's Laboratories Launches Anti-Parasitic Drug Ivermectin	26.11.
Merck to Participate in the Citi 2024 Global Healthcare Conference	26.11.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Data	25.11.
Merck : succès d'une étude dans l'hypertension artérielle	25.11.
Merck Heart Disease Drug Meets Target in Phase 3 Study	25.11.
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis	25.11.
Merck Announces Pivotal Phase 3 Zenith Trial Evaluating Winrevair Met Primary Endpoint At Interim Analysis	25.11.
Merck Asks Shareholders to Reject TRC Capital's 'Mini-Tender' Offer	22.11.
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer	22.11.
Merck : Surendralal Karsanbhai Elected to Merck Board of Directors Form 8 K	22.11.
Top Midday Stories: Intuit Shares Fall After Q2 Guidance Falls Short of Expectations; Honeywell to Sell PPE Business	22.11.
Wall Street warms to AI's glow	22.11.
Merck : le DG d'Emerson Electric va rejoindre le conseil	22.11.
Merck Asthma Drug Singulair Reportedly Linked to Psychiatric Problems in FDA Study	22.11.
Merck Says China Approves Welireg to Treat Von Hippel-Lindau Disease-Associated Tumors	22.11.
Merck Adds Emerson Electric Chief Executive to its Board	22.11.
Merck : feu vert pour Welireg en Chine dans la maladie de VHL	22.11.
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference	22.11.
Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors	22.11.
Merck & Co., Inc.'s WELIREG Approves in China for the Treatment of Adult Patients with Certain Types of Von Hippel-Lindau Disease-Associated Tumors	22.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Merck & Co., Inc.

Aktien

A0YD8Q

US58933Y1055

MRK

Pharmazeutika

Andere Sprachen

Filter